Searchable abstracts of presentations at key conferences in endocrinology

ea0029p986 | Growth hormone IGF axis - basic | ICEECE2012

Designing long acting recombinant proteins: from bench to clinics

Fares F.

One major issue regarding the clinical use of many peptides is their short half-life span in the body, due to the rapid clearance from the circulation. Thus, at the clinical level, there is a need for a regime of frequent injections of the peptides into the patients to overcome this low stability factor. To overcome this problem, we succeeded to add the signal sequence of O-linked oligosaccharides to the coding sequence of the hormones. The cassette gene that has been u...